As of May 7, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,842 confirmed measles cases across 32 states and New York City, with 93% linked to 25 outbreaks—primarily in unvaccinated communities—and Utah leading at 441 cases. This resurgence, following U.S. measles elimination in 2000, stems from declining MMR vaccination coverage below the 95% herd immunity threshold needed to prevent transmission (R0 of 12–18), fueled by hesitancy and imported cases via international travel. Recent CDC reinforcements include state collaborations for contact tracing and vaccination drives, but silent spread via newer testing highlights underreporting risks. Traders should watch weekly CDC updates and end-of-year tallies, as containment success or summer travel could tip total cases higher.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de rougeole aux États-Unis en 2026 ?
Cas de rougeole aux États-Unis en 2026 ?
$7,665,042 Vol.
$7,665,042 Vol.
31 déc. 2026
↑2k
99%
↑3k
60%
↑4k
27%
↑5k
16%
↑7,5k
13%
↑10k
7%
↑12,5k
5%
$7,665,042 Vol.
$7,665,042 Vol.
31 déc. 2026
↑2k
$45,338 Vol.
99%
↑3k
$50,149 Vol.
60%
↑4k
$170,340 Vol.
27%
↑5k
$215,323 Vol.
16%
↑7,5k
$173,315 Vol.
13%
↑10k
$6,491,306 Vol.
7%
↑12,5k
$344,523 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of May 7, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,842 confirmed measles cases across 32 states and New York City, with 93% linked to 25 outbreaks—primarily in unvaccinated communities—and Utah leading at 441 cases. This resurgence, following U.S. measles elimination in 2000, stems from declining MMR vaccination coverage below the 95% herd immunity threshold needed to prevent transmission (R0 of 12–18), fueled by hesitancy and imported cases via international travel. Recent CDC reinforcements include state collaborations for contact tracing and vaccination drives, but silent spread via newer testing highlights underreporting risks. Traders should watch weekly CDC updates and end-of-year tallies, as containment success or summer travel could tip total cases higher.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Dec 1, 2025, 12:56 PM ET
Volume
$7,665,042Date de fin
31 déc. 2026Marché ouvert
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of May 7, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,842 confirmed measles cases across 32 states and New York City, with 93% linked to 25 outbreaks—primarily in unvaccinated communities—and Utah leading at 441 cases. This resurgence, following U.S. measles elimination in 2000, stems from declining MMR vaccination coverage below the 95% herd immunity threshold needed to prevent transmission (R0 of 12–18), fueled by hesitancy and imported cases via international travel. Recent CDC reinforcements include state collaborations for contact tracing and vaccination drives, but silent spread via newer testing highlights underreporting risks. Traders should watch weekly CDC updates and end-of-year tallies, as containment success or summer travel could tip total cases higher.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,665,042Date de fin
31 déc. 2026Marché ouvert
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...As of May 7, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,842 confirmed measles cases across 32 states and New York City, with 93% linked to 25 outbreaks—primarily in unvaccinated communities—and Utah leading at 441 cases. This resurgence, following U.S. measles elimination in 2000, stems from declining MMR vaccination coverage below the 95% herd immunity threshold needed to prevent transmission (R0 of 12–18), fueled by hesitancy and imported cases via international travel. Recent CDC reinforcements include state collaborations for contact tracing and vaccination drives, but silent spread via newer testing highlights underreporting risks. Traders should watch weekly CDC updates and end-of-year tallies, as containment success or summer travel could tip total cases higher.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes